Cyclobenzaprine Hydrochloride
Product Images NDC 21695-036

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Cyclobenzaprine Hydrochloride (NDC 21695-036). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Rebel Distributors, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label (036)

Package Label (036)
This is a product label for tablets of the medication Cyclobenzaprine HCI, with a strength of 5mg each. The label includes lot numbers, expiration dates, and a product code. It also contains a warning to keep the tablets out of reach of children and to store them at a temperature between 59-86°F (15-30°C). The tablets were manufactured by Cadita Pharmaceuticals Inc. in Salisbury, Maryland, USA.*
FDA Label Image

Chemical Structure (Cyclobenzaprine H 01)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.